News & Updates

Show Multimedia Only

Health supplements: Help or hype?

22 Apr 2026 by

A review of 19 meta-analyses shows mixed results on the effects of multivitamin and mineral (MVM) supplementation on health outcomes.

Health supplements: Help or hype?

22 Apr 2026

Optimizing prostate cancer outcomes with 177Lu-PSMA-617 radioligand therapy

22 Apr 2026 by

Radioligand therapy, which uses prostate-specific membrane antigen (PSMA)–targeted agents to deliver tumour‑focused radiation, has become a key treatment for metastatic castration‑resistant prostate cancer (mCRPC). At an industry‑sponsored meeting, Professor Kim-Nguyen Chi of the University of British Columbia in Vancouver, Canada, discussed how PSMA-targeted radioligand therapy, specifically lutetium 177–PSMA 617 (¹⁷⁷Lu-PSMA-617), is reshaping mCRPC management and optimizes outcomes.

Optimizing prostate cancer outcomes with 177Lu-PSMA-617 radioligand therapy

22 Apr 2026

Rilzabrutinib shows potential in patients with uncontrolled asthma

22 Apr 2026

BTK inhibition with rilzabrutinib does not appear to significantly decrease the incidence of loss-of-asthma-control (LOAC) event compared with placebo in patients with moderate-to-severe asthma with uncontrolled symptoms, according to a phase II study. However, the investigational drug has been associated with meaningful symptom improvements over time, despite withdrawal of background therapy.

Rilzabrutinib shows potential in patients with uncontrolled asthma

22 Apr 2026

Two models of palliative care yield similar outcomes in end-stage liver disease

21 Apr 2026

Palliative care delivered by hepatologists yields similar improvements in quality of life (QoL) of patients with end-stage liver disease (ESLD) and is associated with greater patient satisfaction compared with palliative care delivered by specialists, according to a study.

Two models of palliative care yield similar outcomes in end-stage liver disease

21 Apr 2026

Secondary bladder cancer after RT not uncommon in prostate cancer patients

21 Apr 2026 by

A secondary bladder cancer (SBC) rarely occurs among patients with localized prostate cancer who have been treated with radiotherapy (RT), but the incidence rate is not insignificant, reports a study presented at EAU 2026. When it does appear, it usually becomes the primary cause of death in this population.

Secondary bladder cancer after RT not uncommon in prostate cancer patients

21 Apr 2026

T allele presence eases effect of air pollution on RA-ILD risk

21 Apr 2026

People exposed to air pollution for too long are at greater risk of developing rheumatoid arthritis (RA)-associated interstitial lung disease (ILD), with the effect potentially modified according to MUC5B rs35705950 genotype, reveals a study.

T allele presence eases effect of air pollution on RA-ILD risk

21 Apr 2026

Bax24 data boost baxdrostat potential for resistant HTN

21 Apr 2026 by

The results of the phase III Bax24 trial underpin the efficacy of baxdrostat, a selective aldosterone synthase inhibitor (ASI), for the treatment of uncontrolled or resistant hypertension (HTN).

Bax24 data boost baxdrostat potential for resistant HTN

21 Apr 2026

Novel anti-IL-6 antibody shows promise in uveitic macular edema

21 Apr 2026

Interleukin (IL)-6 inhibition with vamikibart is safe and well tolerated and helps improve clinical outcomes in patients with uveitic macular edema (UME), as shown in the phase I DOVETAIL nonrandomized clinical trial.

Novel anti-IL-6 antibody shows promise in uveitic macular edema

21 Apr 2026

Residential radon exposure linked to ovarian cancer

20 Apr 2026

Women residing in homes with high radon levels may be at increased risk of ovarian cancer, as suggested in a study.

Residential radon exposure linked to ovarian cancer

20 Apr 2026

Hybrid obesity care delivers substantial benefits in real-world patients in SG

20 Apr 2026 by

A hybrid obesity care that combines physician-directed glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment and lifestyle coaching via a mobile health app yields meaningful and sustained improvements in weight and metabolic parameters in a real-world setting, as shown in a local study.

Hybrid obesity care delivers substantial benefits in real-world patients in SG

20 Apr 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Health supplements: Help or hype?

Health supplements: Help or hype?

Optimizing prostate cancer outcomes with 177Lu-PSMA-617 radioligand therapy

Optimizing prostate cancer outcomes with 177Lu-PSMA-617 radioligand therapy

Rilzabrutinib shows potential in patients with uncontrolled asthma

Rilzabrutinib shows potential in patients with uncontrolled asthma

Two models of palliative care yield similar outcomes in end-stage liver disease

Two models of palliative care yield similar outcomes in end-stage liver disease

Secondary bladder cancer after RT not uncommon in prostate cancer patients

Secondary bladder cancer after RT not uncommon in prostate cancer patients

T allele presence eases effect of air pollution on RA-ILD risk

T allele presence eases effect of air pollution on RA-ILD risk

Bax24 data boost baxdrostat potential for resistant HTN

Bax24 data boost baxdrostat potential for resistant HTN

Novel anti-IL-6 antibody shows promise in uveitic macular edema

Novel anti-IL-6 antibody shows promise in uveitic macular edema

Residential radon exposure linked to ovarian cancer

Residential radon exposure linked to ovarian cancer

Hybrid obesity care delivers substantial benefits in real-world patients in SG

Hybrid obesity care delivers substantial benefits in real-world patients in SG